Acute HIV Infection Clinical Trial
Official title:
A Double-Blind, Randomized, Placebo-Controlled Clinical Trial of Combination HIV-Specific Broadly Neutralizing Monoclonal Antibodies Combined With ART Initiation During Acute HIV Infection to Induce HIV Remission
A5388 is a phase II, two-arm, randomized, double-blind, placebo-controlled study that will enroll 48 antiretroviral therapy (ART)-naïve adults with acute HIV infection (AHI) in order to determine whether: - Administration of combination HIV-specific broadly neutralizing antibody (bNAb) therapy in addition to ART during acute HIV infection (AHI) will be safe. - Participants who receive combination bNAb therapy in addition to ART during AHI will be more likely to demonstrate a delay in time to HIV-1 RNA ≥1,000 copies/mL for 4 consecutive weeks compared to participants who receive placebo plus ART. - Participants who receive combination bNAb therapy in addition to ART during AHI will demonstrate lower viral reservoirs and enhanced HIV-specific immunity compared to participants who receive placebo plus ART.
n/a
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT02384395 -
Safety and Efficacy of Fixed Dose Combination Dolutegravir/Abacavir/Lamivudine FDC Initiated During Acute HIV Infection
|
N/A | |
Completed |
NCT00734344 -
Pilot Study of Raltegravir/Truvada Versus Efavirenz/Truvada for Adults With Acute IV-1 Infection
|
N/A | |
Completed |
NCT01434706 -
Implementation of Nucleic Acid Amplification Testing Screening to Identify Acute and Early HIV Infection
|
N/A | |
Active, not recruiting |
NCT03711253 -
Empiric Treatment for Acute HIV in the ED
|
Phase 4 | |
Completed |
NCT01154673 -
Intense Acute Infection Study
|
Phase 2/Phase 3 | |
Terminated |
NCT00855413 -
HIV Viremia and Persistence in Acutely HIV-Infected Patients Treated With Darunavir/Ritonavir and Etravirine
|
Phase 4 | |
Completed |
NCT02467439 -
Acute Partner and Social Contact Referral: iKnow
|
N/A | |
Completed |
NCT03579381 -
Specimen Repository for HIV Immunopathogenesis
|
||
Completed |
NCT01369056 -
HAART Adherence Among HIV-infected Persons and the Factors Affecting Treatment Adherence
|
N/A | |
Completed |
NCT02170246 -
Analysis of Telmisartan Administered With Antiretroviral Therapy (ART) in Patients With Acute HIV Infection
|
Phase 1 | |
Completed |
NCT02475915 -
Efficacy of VHM After Treatment Interruption in Subjects Initiating ART During Acute HIV Infection
|
Phase 1/Phase 2 | |
Completed |
NCT02470351 -
Assessment of the HIV CNS Reservoir, Neurological and Neuro-cognitive Effects, and Source of Rebound HIV in CNS
|
N/A | |
Completed |
NCT02750059 -
Using Telmisartan With ART During Acute HIV Infection to Reduce the CNS Reservoirs of HIV and Lymph Node Fibrosis
|
Phase 2 | |
Completed |
NCT00924898 -
Treatment of Acute HIV With Emtricitabine, Tenofovir and Efavirenz (CID 0805)
|
Phase 4 | |
Completed |
NCT02614950 -
Viral Suppression After Analytic Treatment Interruption in Thai Patients Who Initiated Highly Active Antiretroviral Therapy During Acute HIV Infection
|
N/A | |
Completed |
NCT01197027 -
Feasibility and Acceptability Study of an Individual-Level Behavioral Intervention for Individuals With Acute and Early HIV-Infection
|
Phase 3 | |
Active, not recruiting |
NCT02231281 -
Early cART and cART in Combination With Autologous HIV-1 Specific Cytotoxic T Lymphocyte (CTL) Infusion in The Treatment of Acute HIV-1 Infected Adults
|
Phase 3 | |
Recruiting |
NCT05728996 -
Netherlands Cohort Study on Acute HIV Infection
|
||
Recruiting |
NCT00796263 -
Antiretroviral Therapy for Acute and Chronic HIV Infection
|
Phase 3 | |
Recruiting |
NCT00796146 -
Establish and Characterize an Acute HIV Infection Cohort in a High Risk Population
|